MyAverix Finance
US · Healthcare
Genomma Lab Internacional S.A.B. de C.V (GNMLF)
Drug Manufacturers - Specialty & Generic
Genomma Lab Internacional S.A.B. de C.V (GNMLF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-30, reported market cap is $973.79M, P/E ratio is 11.11, net margin is 9.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for GNMLF
Genomma Lab Internacional S.A.B. de C.V (GNMLF) — FAQ
What is Genomma Lab Internacional S.A.B. de C.V's market cap?
Genomma Lab Internacional S.A.B. de C.V (GNMLF) has a reported market cap of $973.79M (data as of 2026-03-30).
What is GNMLF's P/E ratio?
The price-to-earnings (P/E) ratio for Genomma Lab Internacional S.A.B. de C.V (GNMLF) is 11.11 (data as of 2026-03-30).
Does Genomma Lab Internacional S.A.B. de C.V pay a dividend?
Dividend yield is not available in the current snapshot for Genomma Lab Internacional S.A.B. de C.V (GNMLF). Check the MyAverix Finance app for the latest dividend data.
What sector is Genomma Lab Internacional S.A.B. de C.V in?
Genomma Lab Internacional S.A.B. de C.V (GNMLF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is GNMLF listed on?
GNMLF is listed on US.
What is Genomma Lab Internacional S.A.B. de C.V's net margin?
Genomma Lab Internacional S.A.B. de C.V (GNMLF) reports a net margin of 9.2% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.